Santamaría-Corral Guillermo, Senhaji-Kacha Abrar, Broncano-Lavado Antonio, Esteban Jaime, García-Quintanilla Meritxell
Department of Clinical Microbiology, IIS-Fundación Jiménez Díaz, Av. Reyes Católicos 2, 28040 Madrid, Spain.
CIBERINFEC-Infectious Diseases CIBER, 28029 Madrid, Spain.
Antibiotics (Basel). 2023 Jun 22;12(7):1089. doi: 10.3390/antibiotics12071089.
Phage therapy is an alternative therapy that is being used as the last resource against infections caused by multidrug-resistant bacteria after the failure of standard treatments. can cause pneumonia, septicemia, urinary tract, and surgery site infections mainly in immunocompromised people, although it can cause infections in many different patient profiles. Cystic fibrosis patients are particularly vulnerable. In vitro and in vivo studies of phage therapy against include both bacteriophages alone and combined with antibiotics. However, the former is the most promising strategy utilized in clinical infections. This review summarizes the recent studies of phage-antibiotic combinations, highlighting the synergistic effects of in vitro and in vivo experiments and successful treatments in patients.
噬菌体疗法是一种替代疗法,在标准治疗失败后,它被用作对抗多重耐药菌感染的最后手段。主要在免疫功能低下的人群中可引起肺炎、败血症、尿路感染和手术部位感染,不过在许多不同的患者群体中它都可能引发感染。囊性纤维化患者尤其易受影响。针对[具体细菌名称未给出]的噬菌体疗法的体外和体内研究包括单独使用噬菌体以及与抗生素联合使用。然而,前者是临床感染中最具前景的策略。本综述总结了噬菌体 - 抗生素联合使用的近期研究,突出了体外和体内实验的协同效应以及在患者中的成功治疗案例。